Grant: Doctoral: Vanier Canada Graduate Scholarships
McMaster University
$150,000.00
Adipocyte AMP-activated protein kinase (AMPK) as a cellular target to treat obesity-related diseases in vivo: From mechanism to treatment
FY 2018-19
Summary
The rising rates of obesity-related diseases including cardiovascular disease, type II diabetes, and some cancers, pose an immense threat to society. Individuals affected by these diseases have a higher risk of premature death and a decreased quality of life. Finding a new class of therapeutics to manage and treat the symptoms associated with these diseases is of utmost importance. One potential way to prevent or treat these diseases is by increasing the metabolism of adipose tissue. Specifically, increasing the metabolism of brown and beige adipose tissues (BAT) could "suck up" sugars and fats from the system and burn them away as heat as opposed to storing them. The applicant's lab has discovered a crucial molecule, the AMP-activated protein kinase (AMPK), for the function of these adipose tissues and is proposing to develop a new drug using Nano-particles that specifically activate it in BAT to reduce weight gain, blood sugar, and liver fat. Understanding how this molecule works could provide a basis for future therapies specifically targeted to obesity-related diseases. This project has the potential to impact the quality of life of over 7 million Canadians and could address a shortcoming in effective therapies that prevent or treat obesity-related diseases.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
396242
Name
Desjardins Eric M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Adipocyte AMP-activated protein kinase (AMPK) as a cellular target to treat obesity-related diseases in vivo: From mechanism to treatment
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Adipose Tissue Biology; Amp-Activated Protein Kinase; Animal Models; Diabetes; Nano-Particles; Non-Alcoholic Fatty Liver Disease; Non-Shivering Thermogenesis; Obesity; Phosphoproteomics; Rna Sequencing
Abstract
The rising rates of obesity-related diseases including cardiovascular disease, type II diabetes, and some cancers, pose an immense threat to society. Individuals affected by these diseases have a higher risk of premature death and a decreased quality of life. Finding a new class of therapeutics to manage and treat the symptoms associated with these diseases is of utmost importance. One potential way to prevent or treat these diseases is by increasing the metabolism of adipose tissue. Specifically, increasing the metabolism of brown and beige adipose tissues (BAT) could "suck up" sugars and fats from the system and burn them away as heat as opposed to storing them. The applicant's lab has discovered a crucial molecule, the AMP-activated protein kinase (AMPK), for the function of these adipose tissues and is proposing to develop a new drug using Nano-particles that specifically activate it in BAT to reduce weight gain, blood sugar, and liver fat. Understanding how this molecule works could provide a basis for future therapies specifically targeted to obesity-related diseases. This project has the potential to impact the quality of life of over 7 million Canadians and could address a shortcoming in effective therapies that prevent or treat obesity-related diseases.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Desjardins, Eric M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~